The Influence of Probiotics in a Drinkable Yogurt on Skin Health
| Tracking Information | |
|---|---|
| First Received Date ICMJE | March 13, 2009 |
| Last Updated Date | May 15, 2013 |
| Start Date ICMJE | February 2009 |
| Primary Completion Date | April 2010 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
Transepidermal water loss [ Time Frame: baseline, 1 month, 2 months, 3 months, 5 months and 6 months ] [ Designated as safety issue: No ] |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT00864188 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE |
Biopsy markers: transglutaminase, filagrin, involucrin, loricrin (mRNA) [ Time Frame: baseline and at 5 months ] [ Designated as safety issue: No ] |
| Original Secondary Outcome Measures ICMJE | Same as current |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | The Influence of Probiotics in a Drinkable Yogurt on Skin Health |
| Official Title ICMJE | Phase 1 The Influence of Probiotics in a Drinkable Yogurt on Skin Health |
| Brief Summary | The aim of this study is to test if probiotics administered to healthy female subjects in a dairy format have any skin health benefits. |
| Detailed Description | This is a placebo-controlled, double blind, randomized, single center, human clinical trial aimed at assessing the influence of probiotics on skin health in healthy female subjects, when administered in a food matrix over a period of 5 months. It will consist of five groups(40 subjects/group). The first group (1) of subjects will receive acidified milk that does not contain bacterial strains. The second group (2) will receive acidified milk that contains one specific probiotic strain. The third group (3) will receive fermented milk that contains a standard mix of yogurt bacterial strains. The fourth group (4) will receive fermented milk, containing the same standard mix of yogurt bacterial strains as in group 3 plus the same specific probiotic strain as in group 2. Finally, the fifth group (5) will receive fermented milk, containing the same standard mix of yogurt bacterial strains as in group 3 and 4 plus the same specific probiotic strain as in group 2 and 4 plus a mix of antioxidants. This study will address whether: A.The bioefficacy of a specific probiotic strain is influenced by a milk matrix. B.Whether other bacterial strains impact the bioefficacy of this specific probiotic strain, and validate whether or not the bioefficacy is related entirely to the activity of this specific probiotic strain. C.Whether nutritional supplements impact the bioefficacy of a specific probiotic strain. |
| Study Type ICMJE | Interventional |
| Study Phase | Phase 1 |
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Supportive Care |
| Condition ICMJE | Skin Health |
| Intervention ICMJE |
|
| Study Arm (s) |
|
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Completed |
| Enrollment ICMJE | 207 |
| Completion Date | April 2010 |
| Primary Completion Date | April 2010 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Female |
| Ages | 25 Years to 55 Years |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Germany |
| Administrative Information | |
| NCT Number ICMJE | NCT00864188 |
| Other Study ID Numbers ICMJE | 08.29.NRC |
| Has Data Monitoring Committee | No |
| Responsible Party | Nestlé |
| Study Sponsor ICMJE | Nestlé |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Nestlé |
| Verification Date | September 2009 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|